• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

曲唑酮长期效应的急性刺激反应预测

Acute stimulant response prediction of chronic trazodone effects.

作者信息

Little K Y, Gay T L

机构信息

Department of Psychiatry, University of Michigan, Ann Arbor, USA.

出版信息

Prog Neuropsychopharmacol Biol Psychiatry. 1996 Jul;20(5):815-24. doi: 10.1016/0278-5846(96)00061-9.

DOI:10.1016/0278-5846(96)00061-9
PMID:8870066
Abstract
  1. Depressed patients who acutely improve after taking a stimulant drug have a better eventual response to chronic antidepressant treatment than do stimulant non-responders. Unlike the stimulants and most antidepressants, trazodone (TRZ) is not a potent monoamine reuptake inhibitor. 2. The authors tested the hypothesis that acute methylphenidate (MPH) and d-amphetamine (d-AMP) response would not correlate with eventual trazodone response because its site of action was different from other antidepressants. 3. It was found that acute MPH-induced improvement correlated with eventual TRZ-induced improvement to a limited degree. 4. This correlation might reflect serotonin reuptake inhibition by trazodone and suggests that this effect is therapeutically relevant.
摘要
  1. 服用兴奋剂药物后病情急性改善的抑郁症患者,最终对慢性抗抑郁治疗的反应比兴奋剂无反应者更好。与兴奋剂和大多数抗抑郁药不同,曲唑酮(TRZ)不是强效单胺再摄取抑制剂。2. 作者检验了这样一种假设,即急性哌甲酯(MPH)和右旋苯丙胺(d-AMP)反应与最终的曲唑酮反应不相关,因为其作用部位与其他抗抑郁药不同。3. 研究发现,急性MPH诱导的改善与最终TRZ诱导的改善在一定程度上相关。4. 这种相关性可能反映了曲唑酮对血清素再摄取的抑制作用,并表明这种作用具有治疗相关性。

相似文献

1
Acute stimulant response prediction of chronic trazodone effects.曲唑酮长期效应的急性刺激反应预测
Prog Neuropsychopharmacol Biol Psychiatry. 1996 Jul;20(5):815-24. doi: 10.1016/0278-5846(96)00061-9.
2
d-Amphetamine versus methylphenidate effects in depressed inpatients.
J Clin Psychiatry. 1993 Sep;54(9):349-55.
3
Tolerability and efficacy of high-dose moclobemide alone and in combination with lithium and trazodone.高剂量吗氯贝胺单独使用以及与锂盐和曲唑酮联合使用的耐受性和疗效。
J Clin Psychopharmacol. 2000 Jun;20(3):394-5. doi: 10.1097/00004714-200006000-00024.
4
Occurrence of trazodone-induced delirium.曲唑酮所致谵妄的发生情况。
Int Clin Psychopharmacol. 1998 Sep;13(5):225-8. doi: 10.1097/00004850-199809000-00006.
5
Methylphenidate for alpha-interferon induced depression.哌醋甲酯治疗α-干扰素所致抑郁症。
J Psychopharmacol. 2006 Sep;20(5):687-9. doi: 10.1177/0269881106063134. Epub 2006 Mar 13.
6
Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients.通过对抑郁症门诊患者使用缓释制剂进行上市后临床研究,证实曲唑酮对其目标症状(抑郁、焦虑和失眠)具有神经生理学预测的治疗效果。
Neuropsychobiology. 2003;48(4):194-208. doi: 10.1159/000074638.
7
Trazodone for the treatment of neuroleptic-induced acute akathisia: a placebo-controlled, double-blind, crossover study.曲唑酮治疗抗精神病药所致急性静坐不能:一项安慰剂对照、双盲、交叉研究。
Clin Neuropharmacol. 2010 Sep-Oct;33(5):219-22. doi: 10.1097/WNF.0b013e3181ee7f63.
8
Relationship between plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine, and its clinical effect in depressed patients.曲唑酮及其活性代谢物间氯苯哌嗪的血浆浓度与抑郁症患者临床疗效的关系。
Ther Drug Monit. 2002 Aug;24(4):563-6. doi: 10.1097/00007691-200208000-00016.
9
The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorder.每日一次的控释曲唑酮治疗重度抑郁症患者的情绪低落、焦虑、失眠及自杀倾向的疗效与耐受性
Psychopharmacol Bull. 2009;42(4):5-22.
10
A preliminary study of serotonergic antidepressants in treatment of dysthymia.血清素能抗抑郁药治疗心境恶劣障碍的初步研究。
Prog Neuropsychopharmacol Biol Psychiatry. 1992;16(6):933-41. doi: 10.1016/0278-5846(92)90111-q.